Janssen
Rybrevant
Manufacturer:
Janssen
Name:
Rybrevant
HCPCS Code Descriptor:
Injection, amivantamab-vmjw, 2 mg
Category:
J Code
HCPCS:
J9061
NDC(s):
57894-0501-01
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
Rybrevant is an Oncology drug manufactured by Janssen and administered via the Intravenous route of administration. The J Code: J9061 is aligned to the drug Rybrevant.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/22
HCPCS Effective Date:
1/1/22
HCPCS Short Description:
Inj, amivantamab-vmjw
Billing and Coding Guide:
https://www.janssencarepath.com/hcp/sites/www.janssencarepath-v2.com.hcp/files/rybrevant-coding-and-billing.pdf?v=188
Patient Assistance:
http://www.jjpaf.org/